193 related articles for article (PubMed ID: 32859615)
1. Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial.
Brown JC; Zhang S; Ligibel JA; Irwin ML; Jones LW; Campbell N; Pollak MN; Sorrentino A; Cartmel B; Harrigan M; Tolaney SM; Winer EP; Ng K; Abrams TA; Sanft T; Douglas PS; Hu FB; Fuchs CS; Meyerhardt JA
Cancer Prev Res (Phila); 2020 Dec; 13(12):1055-1062. PubMed ID: 32859615
[TBL] [Abstract][Full Text] [Related]
2. The dose-response effect of aerobic exercise on inflammation in colon cancer survivors.
Brown JC; Compton SLE; Meyerhardt JA; Spielmann G; Yang S
Front Oncol; 2023; 13():1257767. PubMed ID: 38148846
[TBL] [Abstract][Full Text] [Related]
3. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Inflammation in Breast Cancer Survivors.
Sturgeon KM; Brown JC; Sears DD; Sarwer DB; Schmitz KH
Med Sci Sports Exerc; 2023 Feb; 55(2):209-215. PubMed ID: 36170550
[TBL] [Abstract][Full Text] [Related]
4. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
[TBL] [Abstract][Full Text] [Related]
5. Randomized Phase II Trial of Exercise, Metformin, or Both on Metabolic Biomarkers in Colorectal and Breast Cancer Survivors.
Meyerhardt JA; Irwin ML; Jones LW; Zhang S; Campbell N; Brown JC; Pollak M; Sorrentino A; Cartmel B; Harrigan M; Tolaney SM; Winer E; Ng K; Abrams T; Fuchs CS; Sanft T; Douglas PS; Hu F; Ligibel JA
JNCI Cancer Spectr; 2020 Feb; 4(1):pkz096. PubMed ID: 32090192
[TBL] [Abstract][Full Text] [Related]
6. The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose-response of randomized clinical trials.
Rahmani J; Manzari N; Thompson J; Gudi SK; Chhabra M; Naik G; Mousavi SM; Varkaneh HK; Clark C; Zhang Y
Clin Transl Oncol; 2020 Jan; 22(1):37-49. PubMed ID: 31006835
[TBL] [Abstract][Full Text] [Related]
7. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
8. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Santa-Maria CA; Coughlin JW; Sharma D; Armanios M; Blackford AL; Schreyer C; Dalcin A; Carpenter A; Jerome GJ; Armstrong DK; Chaudhry M; Cohen GI; Connolly RM; Fetting J; Miller RS; Smith KL; Snyder C; Wolfe A; Wolff AC; Huang CY; Appel LJ; Stearns V
Clin Cancer Res; 2020 Jun; 26(12):3024-3034. PubMed ID: 32071117
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32.
Goodwin PJ; Parulekar WR; Gelmon KA; Shepherd LE; Ligibel JA; Hershman DL; Rastogi P; Mayer IA; Hobday TJ; Lemieux J; Thompson AM; Pritchard KI; Whelan TJ; Mukherjee SD; Chalchal HI; Oja CD; Tonkin KS; Bernstein V; Chen BE; Stambolic V
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25740979
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.
DeCensi A; Puntoni M; Gandini S; Guerrieri-Gonzaga A; Johansson HA; Cazzaniga M; Pruneri G; Serrano D; Schwab M; Hofmann U; Mora S; Aristarco V; Macis D; Bassi F; Luini A; Lazzeroni M; Bonanni B; Pollak MN
Breast Cancer Res Treat; 2014 Nov; 148(1):81-90. PubMed ID: 25253174
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials.
Zhang ZJ; Yuan J; Bi Y; Wang C; Liu Y
Pharmacol Res; 2019 Mar; 141():551-555. PubMed ID: 30664988
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
Anholm C; Kumarathurai P; Pedersen LR; Samkani A; Walzem RL; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
Atherosclerosis; 2019 Sep; 288():60-66. PubMed ID: 31326727
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Exercise Training on Mediators of Inflammation in Breast Cancer Survivors: A Systematic Review with Meta-analysis.
Meneses-Echávez JF; Correa-Bautista JE; González-Jiménez E; Schmidt Río-Valle J; Elkins MR; Lobelo F; Ramírez-Vélez R
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1009-17. PubMed ID: 27197276
[TBL] [Abstract][Full Text] [Related]
14. Effect of aerobic exercise on inflammatory markers in polycystic ovary syndrome: a randomized controlled trial.
Elbandrawy AM; Yousef AM; Morgan EN; Ewais NF; Eid MM; Elkholi SM; Abdelbasset WK
Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3506-3513. PubMed ID: 35647831
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
Esfahanian F; Zamani MM; Heshmat R; Moini nia F
J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
[TBL] [Abstract][Full Text] [Related]
16. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
17. Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting.
Ligibel JA; Meyerhardt J; Pierce JP; Najita J; Shockro L; Campbell N; Newman VA; Barbier L; Hacker E; Wood M; Marshall J; Paskett E; Shapiro C
Breast Cancer Res Treat; 2012 Feb; 132(1):205-13. PubMed ID: 22113257
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.
Carter AM; Bennett CE; Bostock JA; Grant PJ
Diabet Med; 2005 Sep; 22(9):1282-4. PubMed ID: 16108864
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes.
Patterson RE; Marinac CR; Sears DD; Kerr J; Hartman SJ; Cadmus-Bertram L; Villaseñor A; Flatt SW; Godbole S; Li H; Laughlin GA; Oratowski-Coleman J; Parker BA; Natarajan L
J Natl Cancer Inst; 2018 Nov; 110(11):1239-1247. PubMed ID: 29788487
[TBL] [Abstract][Full Text] [Related]
20. Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial.
Raji Lahiji M; Zarrati M; Najafi S; Yazdani B; Cheshmazar E; Razmpoosh E; Janani L; Raji Lahiji M; Shidfar F
Support Care Cancer; 2021 Jul; 29(7):4147-4157. PubMed ID: 33404812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
